SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology
9 references·4 citing·42 second hop
The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology (2016)The State of Cancer Care in America, 2016…Setting Value-Based Payment Goals — HHS Efforts to Improve U.S. Health Care (2015)Setting Value-Based Payment G…In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs (2015)In Support of a Patient-Drive…Changes in Self-reported Insurance Coverage, Access to Care, and Health Under the Affordable Care Act (2015)Changes in Self-reported Insu…Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance (2015)Association Between Geographi…American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)American Society of Clinical …Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (2013)Washington State Cancer Patie…Cancer Drugs in the United States: Justum Pretium—The Just Price (2013)Cancer Drugs in the United St…American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology (2012)American Society of Clinical …Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Projections of the Cost of Ca…Fundamentals of cancer treatment service design: a guideline considering the healing environment concept (2024)Fundamentals of cancer treatm…Bibliometric analysis of cancer care operations management: current status, developments, and future directions (2022)Bibliometric analysis of canc…Making the Case for Improving Oncology Workforce Diversity (2017)Making the Case for Improving…Cost‐related medication nonadherence among adolescent and young adult cancer survivors (2017)Cost‐related medication nonad…Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)Pricing in the Market for Anticancer Drugs (2015)Essential medicines for cancer: WHO recommendations and national priorities (2016)National trends in prescription drug expenditures and projections for 2016 (2016)The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications (2017)The Oregon Health Insurance Experiment: Evidence from the First Year* (2012)The Oregon Experiment — Effects of Medicaid on Clinical Outcomes (2013)Changes in Utilization and Health Among Low-Income Adults After Medicaid Expansion or Expanded Private Insurance (2016)Health and Access to Care during the First 2 Years of the ACA Medicaid Expansions (2017)The Impact of Health Insurance on Preventive Care and Health Behaviors: Evidence from the First Two Years of the ACA Medicaid Expansions (2017)Medical Bankruptcy in the United States, 2007: Results of a National Study (2009)The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors (2015)A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay (2016)Geographic Access to Health Care for Rural Medicare Beneficiaries (2006)Effects of residence and race on burden of travel for care: cross sectional analysis of the 2001 US National Household Travel Survey (2007)Geographic access to cancer care in the U.S. (2008)Impact of Travel Time on Health Care Costs and Resource Use by Phase of Care for Older Patients With Cancer (2019)National and State Estimates of Lost Earnings From Cancer Deaths in the United States (2019)Navigating financial toxicity in patients with cancer: A multidisciplinary management approach (2022)The price of innovation: new estimates of drug development costs (2003)Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study (2015)ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe (2016)Medical financial hardship among cancer survivors in the United States (2019)Net Health Benefits (1998)Essential medicines for universal health coverage (2016)Financial Hardships Experienced by Cancer Survivors: A Systematic Review (2016)Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received (2016)Short screening scales to monitor population prevalences and trends in non-specific psychological distress (2002)Validity study of the K6 scale as a measure of moderate mental distress based on mental health treatment need and utilization (2012)Age-Related Differences in Financial Toxicity and Unmet Resource Needs Among Adolescent and Young Adult Cancer Patients (2019)Medical Financial Hardship in Survivors of Adolescent and Young Adult Cancer in the United States (2021)Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery (2022)Hospital Readmissions Reduction Program (2015)Association Between Hospital Participation in a Medicare Bundled Payment Initiative and Payments and Quality Outcomes for Lower Extremity Joint Replacement Episodes (2016)Cost of Joint Replacement Using Bundled Payment Models (2017)Delivering affordable cancer care in high-income countries (2011)Medical Care Costs Associated with Cancer Survivorship in the United States (2020)Patient Experience and Attitudes Toward Addressing the Cost of Breast Cancer Care (2014)The State of Cancer Care in America, 2014: A Report by the American Society of Clinical Oncology (2014)Measuring the Value of Prescription Drugs (2015)
this work references cited by second hop

References

  • 2011Projections of the Cost of Cancer Care in the United States: 2010-20202,653 cited
  • 2015Setting Value-Based Payment Goals — HHS Efforts to Improve U.S. Health Care938 cited
  • 2015American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options916 cited
  • 2013Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis698 cited
  • 2015Changes in Self-reported Insurance Coverage, Access to Care, and Health Under the Affordable Care Act655 cited
  • 2012American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology650 cited
  • 2013Cancer Drugs in the United States: Justum Pretium—The Just Price284 cited
  • 2015Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance264 cited
  • 2015In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs145 cited

Cited by

  • 2017Cost‐related medication nonadherence among adolescent and young adult cancer survivors83 cited
  • 2017Making the Case for Improving Oncology Workforce Diversity31 cited
  • 2022Bibliometric analysis of cancer care operations management: current status, developments, and future directions23 cited
  • 2024Fundamentals of cancer treatment service design: a guideline considering the healing environment concept

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

4 cited